Navigation Links
EPA holds seminar on air pollution and cardiovascular disease

WASHINGTON The U.S. Environmental Protection Agency is sponsoring a seminar called "Breathe Cleaner, Live Longer: Understanding Air Pollution after 40 Years." The event is co-sponsored by the American Heart Association and the U.S. House of Representatives Committee on Science and Technology. World-renowned scientific experts will discuss the impacts of air pollution on life expectancy and cardiovascular disease, and how improvements in air quality have reduced illness.

The seminar is the first in a series that will be held throughout 2010 in Washington, D.C. as part of Air Science 40, a year-long celebration of how EPA's air research has made a difference in air pollution and its impacts on human health.

WHO: Kevin Teichman, Ph.D., deputy assistant administrator of EPA's Office of Research and Development
Rep. Bart Gordon, Chairman, Committee on Science and Technology, U.S. House of Representatives (invited)
Other EPA scientists
University scientists

WHAT: "Breathe Cleaner, Live Longer: Understanding Air Pollution after 40 Years"

WHEN: Friday, May 21, from 12:00 p.m. to 1:30 p.m.

WHERE: Rayburn House Office Building, Room 2325

To register for the seminar, contact Michelle Limes at the American Heart Association at 202-785-7949 or


Contact: Dave Ryan
U.S. Environmental Protection Agency

Page: 1

Related biology news :

1. New ORNL carbon composite holds promise for bionics
2. Orange corn holds promise for reducing blindness, child death
3. New map of variation in maize genetics holds promise for developing new varieties
4. Energy experts helping Australian households reduce carbon emissions
5. Canadian research breakthrough holds promise for development of effective cancer therapies
6. Nanotechnology holds promise for STD drug delivery
7. New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease
8. High blood sugars impact on immune system holds clues to improving islet cell transplants
9. Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening
10. Research identifies type of vaccine that holds promise in protecting against TB
11. New synthetic form of protein holds promise to stop cancer spread
Post Your Comments:
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Global demand ... 4.6 percent through 2020 to $7.2 billion.  This ... and beverages, cleaning products, biofuel production, animal feed, ... biotechnology, diagnostics, and biocatalysts). Food and beverages will ... driven by increasing consumption of products containing enzymes ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
Breaking Biology Technology: